Searchable abstracts of presentations at key conferences in endocrinology

ea0022p249 | Clinical case reports and clinical practice | ECE2010

Cushing syndrome in patient with thyroid orbitopathy (case report)

Vanuga Peter , Kulich Michal , Pavai Dusan

Authors present a 35-year-old female with thyroid orbitopathy (EO) associated with Graves disease. After initial antithyroid therapy, thyroidectomy was indicated and performed uneventenfully. Due to persisting severe clinically active EO, thyroablative therapy with 131I was performed three years later, intravenous pulse of methylprednisolone was given and consecutive oral therapy with prednisone initiated. This caused weight gain (from 63 to 80 kg) and iatrogenic Cu...

ea0032p963 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Pasireotide in treatment of Cushing’s disease: our first experience

Vanuga Peter , Kentos Peter , Pavai Dusan , Pura Mikulas

Background: Although the excision of ACTH-producing tumors is the principal treatment for Cushing’s disease (CD), pharmacologic treatment has a well-established role. As corticotroph adenomas express somatostatin (SST) receptors (SSTRs), pasireotide – a pluripotent somatostatin analogue, acting on four of five SSTRs has a potential role in treatment of CD among various medical agents.Case report: We report a 39-year-old female with recurrence o...

ea0063ep96 | Pituitary and Neuroendocrinology | ECE2019

Combination of cushing’s syndrome and acromegaly: a rare case report

Sagova Ivana , Pavai Dusan , Kantarova Daniela , Dragula Milan , Vanuga Anton , Vanuga Peter

Cushing’s syndrome (CS) is a relatively rare disease characterized by autonomous hypersecretion of cortisol. The incidence of CS is estimated to be equal to 2–3 cases per million inhabitants per year.The incidence of acromegaly is 3–4 patients per 1 000000 per year. The disease is caused by hypersecretion of growth hormone which is mainly caused by benign tumour of the pituitary gland. In our case report we present a 41 - year - old woman suffering from both Cus...

ea0070ep322 | Pituitary and Neuroendocrinology | ECE2020

Heart failure as a first manifestation of acromegaly - A case report

Sagova Ivana , Pavai Dusan , Dragula Milan , Kantarova Daniela , Vanuga Anton , Vaňuga Peter

Acromegaly is a rare disease, which is mainly caused by benign tumour of the pituitary gland. Long-term presence of elevated growth hormone (GH) and insulin like growth factor 1 (IGF-1) levels accompanying this disease is associated with rheumatologic, cardiovascular, pulmonary and metabolic complications. Cardiovascular complications of acromegaly include a cardiomyopathy, arterial hypertension, arrhytmias, valvulopathy as well as endothelial dysfunction. Cardiovascular disea...

ea0056ep106 | Pituitary and Neuroendocrinology | ECE2018

Rare combination of Acromegaly and Klinefelter syndrome

Sagova Ivana , Pavai Dusan , Stancik Matej , Kantarova Daniela , Urbankova Helena , Gregova Juliana , Vanuga Anton , Vanuga Peter

Acromegaly is a rare disorder usually caused by a benign tumour of the pituitary gland. Long-term presence of elevated growth hormone (GH) and insulin like growth factor I (IGF-I) levels accompanying this disease is associated with complications such as heart failure, cerebrovascular disease, diabetes mellitus, sleep apnoea and arthropathy. Incidence of acromegaly is 3-5 patients per million per year. Klinefelter syndrome is ...

ea0056p175 | Bone ' Osteoporosis | ECE2018

Acromegaly patients with vertebral fractures, have lower trabecular bone score despite no difference in bone mineral density, than non-fractured patients and healthy controls

Kuzma Martin , Vanuga Peter , Sagova Ivana , Pavai Dusan , Jackuliak Peter , Killinger Zdenko , Binkley Neil , Genant Harry , Payer Juraj

Introduction: Patients with acromegaly, despite normal or even high bone mineral density (BMD), have prevalent vertebral fractures (VFs). HR-pQCT studies in acromegaly have proposed that impaired trabecular bone microarchitecture possibly plays a role in fragility fracture development. As such, we hypothesized that trabecular bone score (TBS) would be low in patients with acromegaly.Aim of the study: To compare BMD and TBS in acromegaly patients with and...